CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 100 enrolled
Drug / intervention
Bio Gelee Royale Forte +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06573814
NCT06573814Phase 2Completed

A Randomized, Triple-blind, Placebo Controlled, Parallel Clinical Trial to Investigate the Efficacy of Bio Gelee Royale Forte on Immune Health in Healthy Adults

Medex d.o.o.·interventional·Posted Aug 27, 2024·Updated Apr 29, 2025

In Brief

A Phase 2 clinical trial evaluating Bio Gelee Royale Forte and Placebo for Upper Respiratory Tract Infection and URTI. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The objective of this study is to evaluate the safety and efficacy of Bio Gelee Royale Forte compared to placebo on frequency, severity, and duration of upper respiratory tract infections (URTIs) among adults who are otherwise healthy but susceptible to URTIs during cold and flu season. Additionally, the safety and tolerability of Bio Gelee Royale Forte, as compared to placebo, will be measured by the occurrence of and/or changes in treatment emergent adverse effects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--

Timeline

Phase 2CompletedFinished
20252026
First PostedAug 27, 2024
Enrollment StartOct 25, 2024
Primary CompletionApr 1, 2025
TodayJul 1, 2026
Enrollment to primary: 5 monthsPosted 1.8 years ago

Interventions

Bio Gelee Royale Fortedietary

Two capsules of Bio Gelee Royale Forte will be taken in the morning on empty stomach once per day for 98 days.

Placeboother

Two capsules of placebo will be taken in the morning on empty stomach once per day for 98 days.